Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
32.60
+0.05 (0.15%)
Jun 6, 2025, 1:30 PM CST

Sinphar Pharmaceutical Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
306.71304.71375.17224.64-38.14-28.51
Upgrade
Depreciation & Amortization
245.06243.47230.04248.7247.33235.5
Upgrade
Other Amortization
13.913.913.4918.0122.0414.93
Upgrade
Loss (Gain) From Sale of Assets
2.812.48-5.130.811.5-0.14
Upgrade
Loss (Gain) From Sale of Investments
-0.33-0.3----
Upgrade
Provision & Write-off of Bad Debts
0.140.141.680.472.54-1.83
Upgrade
Other Operating Activities
24.67-3.62-187.15-26.55-190.8-160.81
Upgrade
Change in Accounts Receivable
-50.57-17.727.29-73.59-84.1136.61
Upgrade
Change in Inventory
108.9124.29-102.18-39.62-15.95-114.45
Upgrade
Change in Accounts Payable
-54.6-106-31.97121.927.05-15.78
Upgrade
Change in Unearned Revenue
-0.5611.77-10.912.92-4.1614.82
Upgrade
Change in Other Net Operating Assets
2.0720.37-13.95-52.42188.2466.06
Upgrade
Operating Cash Flow
598.2593.51296.37425.3135.54146.39
Upgrade
Operating Cash Flow Growth
41.47%100.26%-30.31%213.77%-7.41%-
Upgrade
Capital Expenditures
-171.1-240.44-295.51-141.48-146.18-144.01
Upgrade
Sale of Property, Plant & Equipment
0.480.486.30.240.530.49
Upgrade
Sale (Purchase) of Intangibles
-15.78-16.28-5.43-11.96-15.26-13.76
Upgrade
Investment in Securities
-192.66-136.62-2.4533.760.33-5.03
Upgrade
Other Investing Activities
1.351.77-37.48-4.8-45.02-3.38
Upgrade
Investing Cash Flow
-377.7-391.08-334.56-124.24-205.6-165.68
Upgrade
Short-Term Debt Issued
----35106
Upgrade
Long-Term Debt Issued
-5016018085220.89
Upgrade
Total Debt Issued
5050160180120326.9
Upgrade
Short-Term Debt Repaid
--30-47-140--
Upgrade
Long-Term Debt Repaid
--62.36-81.1-259.07-138.92-75.16
Upgrade
Total Debt Repaid
-172.5-92.36-128.1-399.07-138.92-75.16
Upgrade
Net Debt Issued (Repaid)
-122.5-42.3631.9-219.07-18.92251.73
Upgrade
Issuance of Common Stock
----15.587.9
Upgrade
Common Dividends Paid
-167.72-167.72-167.72-33.54-33.54-33.55
Upgrade
Other Financing Activities
1115.15-10.72159.8392.64
Upgrade
Financing Cash Flow
-289.22-209.08-120.67-263.33122.95318.73
Upgrade
Foreign Exchange Rate Adjustments
10.067.83-4.25.04-1.883.61
Upgrade
Net Cash Flow
-58.661.18-163.0742.7751.02303.05
Upgrade
Free Cash Flow
427.1353.080.86283.82-10.642.38
Upgrade
Free Cash Flow Growth
483.21%40955.23%-99.70%---
Upgrade
Free Cash Flow Margin
13.44%11.21%0.03%9.93%-0.44%0.10%
Upgrade
Free Cash Flow Per Share
2.351.950.011.56-0.060.01
Upgrade
Cash Interest Paid
36.7636.4933.6527.6424.8626.16
Upgrade
Cash Income Tax Paid
5.495.357.3747.144.3570
Upgrade
Levered Free Cash Flow
263.24232.08-125.83206.6165.9588.23
Upgrade
Unlevered Free Cash Flow
286.29255.06-104.76223.9981.45103.55
Upgrade
Change in Net Working Capital
-4.77-68.68227.8113.42-87.75-87.27
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.